WIRB-Copernicus Group Reveals Results from 2015 Institutional Review Board (IRB) Performance Report
Comprehensive report analyzes data from 131 U.S.-based hospital and university IRBs PRINCETON, N.J., Dec. 23, 2015 – WIRB-Copernicus Group® (WCG™), the world’s largest provider of regulatory and ethical review services and software to support clinical research, today announced the release of top-level findings from its “Institutional IRB Performance: 2015 Optimizing and Benchmarking Report.” “As government […]
WCG Foundation Launches to Spur Global Clinical Research
WCG’s Chairman & CEO, Donald A. Deieso, PhD, and WCG Foundation’s Executive Director, Marjorie A. Speers, PhD are interviewed by DDNews’ Lloyd Dunlap. Publication: DDNews To read the article, please click here.
How Precision Medicine is Impacting R&D Strategies
WCG’s Chief Medical Officer, Lindsay McNair, MD, MPH, MSBioethics provides perspective on precision medicine for the PharmaVOICE “Year in Preview” issue. Publication: PharmaVOICE To read the article, please click here.
WCG Foundation to Offer Ethics Training, Education
WCG Foundation’s Executive Director, Marjorie A. Speers, PhD is interviewed by CenterWatch Weekly’s Ron Rosenberg. Publication: CenterWatch Weekly
WIRB-Copernicus Group to Co-present Nine Sessions at Public Responsibility in Medicine and Research Conference
PRINCETON, N.J., Nov. 13, 2015 – WIRB-Copernicus Group® (WCG™), the world’s largest provider of regulatory and ethical review services and software to support clinical research, today announced that six of its thought leaders are presenting nine sessions at the Public Responsibility in Medicine & Research (PRIM&R) Advancing Ethical Research (AER) 2015 Conference, which is being […]
WIRB-Copernicus Group Launches Nonprofit WCG Foundation to Improve Global Clinical Research
WIRB-Copernicus Group (WCG) announces the launch of WCG Foundation. WCG Foundation is the first 501(c)(3) public charity founded by an independent institutional review board (IRB) to strengthen protections for research participants and improve health and well-being worldwide. WCG Foundation will initially focus on three programs: advancing education and training in research ethics at U.S. academic institutions, […]
WIRB-Copernicus Group to Host Biosafety Management Webinar to Help Improve Oversight of Research with Biological Materials
This session will propose practical solutions to real-world biosafety issues PRINCETON, NJ, Oct. 30, 2015 – WIRB-Copernicus Group® (WCG™), the world’s largest provider of regulatory and ethical review services and software to support clinical research, today announced that it will be hosting a webinar, entitled: “Biosafety Program Oversight in 2015: Managing New Challenges with Limited […]
A Look at What’s Not in The NPRM
WCG’s Chief Compliance Officer, David Forster, JD, MA, CIP and Copernicus Group IRB’s Vice President, Quality Management, David Borasky, MPH, CIP are interviewed by Report on Research Compliance’s Theresa Delfino. Publication: Report on Research Compliance
WIRB-Copernicus Group Biosafety Experts to Lead Human Gene Transfer Workshop at Annual American Biological Safety Conference
Session will provide an overview of industry challenges, risk assessment development, and the regulatory environment for human gene transfer research PRINCETON, N.J., Oct. 9, 2015 – WIRB-Copernicus Group® (WCG™), the world’s largest provider of regulatory and ethical review services and software to support clinical research, announced today that two experts from its WCG Biosafety™ division […]
WIRB-Copernicus Group and the Prostate Cancer Clinical Trials Consortium Announce New Partnership to Improve Efficiency of Oncology Research Reviews
WIRB-Copernicus Group (WCG) and Prostate Cancer Clinical Trials Consortium (PCCTC) announced their new partnership to enhance the quality and efficiency of the Consortium’s research review process. PCCTC joins the nation’s most prominent cancer research institutions in relying on WCG for the review of its cancer research protocols and related study documents. WCG Oncology™, WCG’s cancer-focused […]